Earlier today we entered in a new trade in the IWM (read here) based on a few factors, most notably the pattern of increased downward volatility in the first few weeks of a new quarter …
Continue readingGILD
The volatility in the Biotech sector over the last week (like the iShares Nasdaq Biotech Index (IBB) down 7% and at one point down 10% yesterday!) has raised some eyebrows as it marks one of …
Continue reading
Here is some generally directional, untied options activity that caught my eye during Tuesday’s trading: 1. FXE – minutes before the close the etf that tracks the Euro saw a massive put spread purchase. When the etf was …
Continue reading
Adam Feuerstein of TheStreet.com had a good post this morning on the potential for a re-rating in Biotechs as they are one of the cheapest sectors in the market relative to expected growth. (Read here …
Continue reading
On October 31st GILD shares were trading at new all time highs, gaining 57% on the year, or about $80 billion in market cap. Since those highs the stock has sold off almost 15%, and …
Continue reading
For the second year in a row, Healthcare is leading the pack by way of sector leadership: The chart of the XLV over the last three years is a work of art, up about 110% …
Continue reading
Event: GILD reports its Q3 results today after the market close. The options market is implying a one day move of about 4.75%, which is above both the 4 quarter average of 2.75% and the …
Continue reading
Event: INTC reports its Q3 earnings today . The options market is implying about a 6% one day move, which is slightly above both the 4 qtr avg of about 3.5%, and the 8 qtr avg of …
Continue reading
Early in today’s session, GILD fell 8% in 20 minutes, an incredibly steep selling cascade for a $150 billion market cap company: This type of price action wouldn’t be that surprising in a $5 billion …
Continue reading
Back in March the biotechnology sector was hard hit hard alongside social media, solar and 3d printing. Since then, most of these sectors have recovered most of their losses from that sell-off. Which brings us …
Continue reading